ECOVYST INC (ECVT)
Materials · Specialty Chemicals · NYSE
Ecovyst is a specialty chemicals provider specializing in performance catalysts and high-purity sulfuric acid for industrial and environmental applications.
What ECOVYST INC does
Ecovyst Inc. is a specialty chemicals company that provides advanced material solutions and catalyst technologies. The company operates primarily through segments focused on high-performance silica catalysts and engineered silica materials, as well as high-purity sulfuric acid and related chemical services. Their products are essential in applications ranging from plastic production and refining to environmental emission control and renewable energy processes.
Themes: catalyst technology, high-purity chemicals, industrial materials, emission control, refining services
Fundamentals
- Price$9.97 as of 2026-10-21 close
- Market cap$1.1B as of 2026-07-31 (share count; price 2026-10-21)
- 1-year return+22.5% 2025-10-21 close $8.14 → 2026-10-21 close $9.97
- P/En/a negative earnings
- Net margin-9.8% FY2025, SEC XBRL
- Gross margin+21.8% FY2025, SEC XBRL
- ROE-11.8% FY2025, SEC XBRL
- ROIC+2.9% NOPAT / (debt + equity - cash), average capital — 10-K FY2025 (year ended 2025-12-31)
- Debt / equity0.84 borrowings, leases excluded / equity — 10-Q/10-K balance sheet 2026-06-30
- Revenue growth (YoY)+20.9% FY2025, SEC XBRL
- Revenue CAGR (3y)-4.1% SEC XBRL
- Beta0.98 as of 2026-09-03
- Last reported earnings2026-08-05 SEC EDGAR Form 8-K (Item 2.02)
Dividend: at least 2 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How ECVT compares in its sector
- net profit marginbottom 25% 125 covered Materials peers, as of 2026-09-03
- operating marginmiddle range 108 covered Materials peers, as of 2026-09-03
- gross marginmiddle range 92 covered Materials peers, as of 2026-09-03
- return on equitymiddle range 144 covered Materials peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 127 covered Materials peers
- free cash flow (absolute dollars, latest fiscal year)middle range 122 covered Materials peers, as of FY2025
Position among covered Materials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage
Not assessed — last reported dividend predates the accounts. The most recent fiscal year in which ECVT reported a dividend payment is FY2021, while its reported financial statements run through FY2025. Coverage is therefore not assessed for the latest year — an FY2021 ratio would not describe ECVT today.
Coverage is derived from reported SEC EDGAR XBRL figures, comparing dividends paid against net income and free cash flow for the SAME fiscal year. It is not shown here because the latest fiscal year with a reported dividend payment (FY2021) is older than the latest year of reported financial statements (FY2025), so any ratio would describe an out-of-date year. Informational only — not financial advice.
Quarterly results
| Quarter | Revenue | Gross profit | Operating income | Net income | Diluted EPS | Operating cash flow | Capex |
|---|---|---|---|---|---|---|---|
| Q2 FY2026 2026-06-30 | $250M | $50M | $19M | $8M | $0.07 | $34M† | $31M† |
| Q1 FY2026 2026-03-31 | $215M | $36M | $13M | $4M | $0.04 | $17M | $14M |
| Q4 FY2025 2025-12-31 | $199M | $47M | $22M | $6M | $0.05 | $42M† | $19M† |
| Q3 FY2025 2025-09-30 | $205M | $52M | $28M | -$79M | -$0.69 | $55M† | $12M† |
| Q2 FY2025 2025-06-30 | $176M | $40M | $16M | $6M | $0.05 | $33M† | $22M† |
| Q1 FY2025 2025-03-31 | $143M | $19M | -$981000 | -$4M | -$0.03 | $10M | $17M |
| Q4 FY2024 2024-12-31 | $149M | $43M | $22M | -$30M | -$0.26 | $43M† | $13M† |
| Q3 FY2024 2024-09-30 | $154M | $45M | $28M | $14M | $0.12 | $60M† | $6M† |
† Not filed as a discrete quarter: derived from the company's own year-to-date figures (for example the fourth quarter as the fiscal year minus the first nine months). A derived per-share figure is approximate, because the share count moves within the year.
Balance sheet at 2026-06-30
- Cash and equivalents$88M
- Total debt$493M borrowings only; leases excluded
- Net debt$405M total debt − cash − short-term investments
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
How ECOVYST INC looks technically
ECOVYST INC (ECVT) is trading 15.4% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 37 trading days ago — a "death cross", a bearish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 14, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 44, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 5 trading days ago (its momentum flipped positive). It made a new 20-day low about 17 trading days ago. It is 33.9% below its highest point of the past year. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 6% of the past ~6 months), which often precedes a bigger move.
Trend
8
| Distance from the 200-day | it is trading 15.4% below its 200-day average, the long-term trend line — a long-term downtrend | -15.4% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $10.20 | $10.20 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $11.79 | $11.79 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 15 calendar days ago — the swings before that are what the structure reading is measured on | 15 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes above 10.5. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible downward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 37 trading days ago — a "death cross", a bearish long-term signal | 37 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 14, below the 25 that marks a real trend) | 14.4 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 44, neither overbought (above 70) nor oversold (below 30) | 44.0 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($9.76 to $10.50) — its "stochastic" reading is 28 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 28.4 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 5 trading days ago (its momentum flipped positive) | 5 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $15.09 | $15.09 |
|---|---|---|
| From the 52-week high | it is 33.9% below its 52-week high (its highest price of the past year) | -33.9% |
| Above the 52-week low | it is 34.5% above its 52-week low (its lowest price of the past year) | +34.5% |
| Below the 52-week high | it is 33.9% below its highest point of the past year | 33.9% |
| Since a 20-day breakout | it made a new 20-day low about 17 trading days ago | 17 sessions |
| Since a 55-day breakout | it made a new 55-day low about 17 trading days ago | 17 sessions |
| All-time high | its highest closing price on record is $18.90 (set on 2021-03-09) | $18.90 |
| Given back of the 52-week move | over the past year its closes ranged ($7.84 to $14.97), and it has given back well over two thirds of its rise from last year’s low — 70% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $10.34 to $10.56. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 70.1% |
| From the all-time high | it is 47.2% below its all-time high | -47.3% |
| Nearest price level | it is trading 0.8% above a support level at $9.89 — a price it turned at three times since 2026-08-12, most recently on 2026-09-01. Since 2024-10-21 it has 12 such levels below the current price and 3 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.8% |
| All-time low | its lowest closing price on record is $5.24 (set on 2025-04-09) | $5.24 |
| Above the all-time low | it is 90.3% above its all-time low | +90.3% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 6% of the past ~6 months), which often precedes a bigger move | 6th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.2605 between its high and its low — about 2.6% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.2605 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $9.77 and $10.41 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $9.77 – $10.09 – $10.41 |
| Typical daily range (% of price) | its price moves about 2.6% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.6% |
| Stretch from the 200-day average | it is trading 7.0 daily ranges below its 200-day average price (15.4% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 7.0 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.14× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
2
| Since a bullish engulfing | 4 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 4 sessions ago |
|---|---|---|
| Since a bearish engulfing | 2 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 2 sessions ago |
Price gaps
2
| Gap at the open | it opened on 2026-10-21 0.2% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.2% |
|---|---|---|
| Gap filled | a 2.6% gap up opened on 2026-09-15 has been "filled" 17 sessions ago — price traded back through the level the gap left behind, and it took 9 sessions to close | 17 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 3 sessions in a row, a -3.02% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 3 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 4.0 percentage points (the stock lost 4.0% while the market lost 0.1%) | -4.0% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 24.4 percentage points (the stock lost 21.1% while the market gained 3.3%) | -24.4% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 37.7 percentage points (the stock lost 27.9% while the market gained 9.8%) | -37.7% |
| vs market, 12 months | over the past 12 months this stock beat the market by 7.3 percentage points (the stock gained 22.5% while the market gained 15.2%) | +7.3% |
Signal agreement
2
| Bullish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bullish state: MACD momentum is positive — these describe past price behaviour, not a forecast | 1 of 9 |
|---|---|---|
| Bearish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 2.4% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-15 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thick, spanning 12.8% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | -2.4% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 17% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $11.95 — a volume-weighted average of daily closes over 199 sessions, not a true tick-by-tick VWAP. | -16.6% |
|---|---|---|
| Vs the average paid since it last reported | the price is 3% below the average price paid since it last reported on 2026-08-05 (its 8-K), so the typical buyer over that stretch is under water. That average is $10.28 — a volume-weighted average of daily closes over 55 sessions, not a true tick-by-tick VWAP. | -3.0% |
Price levels it has turned at before
ECVT last closed at $9.97 on 2026-10-21. Since 2024-10-21 it has turned at 12 prices below its last close and 3 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $9.89 | Support | 0.8% below the last close | turned there three times · 2026-08-12 to 2026-09-01 |
| $9.66 | Support | 3.1% below the last close | turned there four times · 2025-09-11 to 2026-10-01 |
| $10.49 | Resistance | 5.2% above the last close | turned there twice · 2026-09-03 to 2026-10-06 |
| $10.76 | Resistance | 7.9% above the last close | turned there twice · 2026-03-09 to 2026-08-19 |
| $8.91 | Support | 10.7% below the last close | turned there three times · 2025-07-10 to 2025-11-12 |
| $15.01 | Resistance | 50.6% above the last close | turned there twice · 2026-05-06 to 2026-05-14 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes above $10.50.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $8.29 and $9.13 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close above $10.50.
This reading has stood for 7 trading days, since 2026-10-13.
Read from daily closes as of 2026-10-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Trading below the 50-day moving average · Pulled back from the 12-month high · MACD just crossed bullish (12/26/9) · in a Bollinger Band volatility squeeze · trendless / choppy (low ADX) | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low · bollinger bands
Based on daily closing prices as of 2026-10-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$15.17 range $13.00 – $17.00; median $15.50
Analyst estimates, as of 2026-10-15. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for ECVT
- Consensus EPS estimate$0.2111 next reporting period, as of 2026-10-15
- Estimate change, 30 days+$0.006 (+2.9%) from $0.2051, on 2026-09-10, 35-day window
- Readings revised upward22% of 9 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Significant leverage and long-term debt obligations","Exposure to cyclical demand in industrial end-markets","Risks related to hedging activities and foreign currency fluctuations"]
What changed in the latest 10-Q
AI-assisted comparison of ECVT's 10-Q filed 2026-08-06 against the prior one filed 2026-05-05.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-08-06) compares results for the three months ended June 30, 2026 and 2025.
- Newer filing (2026-08-06) discloses Q2 2026 sales increased $73.9 million to $250.0 million.
- Newer filing (2026-08-06) discloses Q2 2026 gross profit increased $9.6 million to $49.8 million.
- Newer filing (2026-08-06) discloses Q2 2026 operating income increased by $3.6 million to $19.4 million.
- Newer filing (2026-08-06) provides a Q2 2026 and Q2 2025 unaudited condensed consolidated statements of income table.
- Newer filing (2026-08-06) attributes part of Q2 2026 sales increase to favorable contractual pricing for regenerated sulfuric acid and increased volume, partially offset by lower pricing due to customer mix and pass-through of lower variable freight costs.
- Newer filing (2026-08-06) discloses Q2 2026 sales increase components: higher average selling prices of $57.5 million, including approximately $55 million pass-through of higher sulfur costs, and higher sales volume of $16.4 million.
- Newer filing (2026-08-06) attributes Q2 2026 sales volume increase to higher regenerated sulfuric acid sales from strong demand and less customer downtime, plus higher virgin sulfuric acid sales from increased customer demand and Waggaman, Louisiana contribution.
- Newer filing (2026-08-06) discloses Q2 2026 gross profit increase components: higher sales volume of $6.8 million, higher average selling prices of $2.5 million excluding sulfur pass-through, and $0.3 million favorable overall variable and fixed manufacturing costs.
- Newer filing (2026-08-06) discloses Q2 2026 favorable manufacturing costs driven by lower variable costs including variable freight, partially offset by higher fixed manufacturing costs from Waggaman, Louisiana acquisition, general inflation and higher transportation costs.
- Newer filing (2026-08-06) discloses Q2 2026 selling, general and administrative expenses were $17.4 million, a decrease of $0.2 million from $17.6 million.
- Newer filing (2026-08-06) discloses Q2 2026 other operating expense, net was $13.0 million, an increase of $6.2 million from $6.8 million, due to increased loss on disposal of assets of $2.0 million and transaction costs of $6.6 million, partially offset by a decrease in other costs of $2.4 million primarily related to tax consulting professional fees.
- Removed:
- Older filing (2026-05-05) compares results for the three months ended March 31, 2026 and 2025.
- Older filing (2026-05-05) discloses Q1 2026 sales increased $71.9 million to $215.0 million.
- Older filing (2026-05-05) discloses Q1 2026 gross profit increased $17.3 million to $36.4 million.
- Older filing (2026-05-05) discloses Q1 2026 operating income increased by $13.5 million to $12.5 million.
- Older filing (2026-05-05) provides a Q1 2026 and Q1 2025 unaudited condensed consolidated statements of income table.
- Older filing (2026-05-05) discloses Q1 2026 increase in operating income was due to an increase in gross profit, partially offset by higher selling, general and administrative expenses.
- Older filing (2026-05-05) discloses Q1 2026 sales increase components: higher average selling prices of $39.7 million, including approximately $33 million pass-through of higher sulfur costs, and higher sales volume of $32.2 million.
- Older filing (2026-05-05) attributes Q1 2026 sales volume increase to Waggaman, Louisiana contribution, higher virgin sulfuric acid demand and higher regeneration services driven by less customer downtime.
- Older filing (2026-05-05) discloses Q1 2026 gross profit increase components: higher sales volume of $14.6 million and higher average selling prices of $6.7 million excluding sulfur pass-through, partially offset by higher manufacturing costs of $4.0 million.
- Older filing (2026-05-05) discloses Q1 2026 higher manufacturing costs driven by additional fixed costs from Waggaman, Louisiana, higher total turnaround costs of approximately $2 million, general inflation and higher transportation costs.
- Older filing (2026-05-05) discloses Q1 2026 selling, general and administrative expenses were $19.1 million, an increase of $2.6 million from $16.5 million, driven by stock compensation increase of $0.9 million, other compensation-related expenses of $1.2 million and other expenses of $0.5 million.
- Older filing (2026-05-05) discloses Q1 2026 other operating expense, net was $4.8 million, an increase of $1.2 million from $3.6 million, driven by transaction costs increase of $0.4 million and other costs increase of $0.8 million primarily related to integration, restructuring and legal charges.
- Reworded:
- Newer filing (2026-08-06) refers to 'our regenerated sulfuric acid product' in the Sales and Seasonality sections, while older filing (2026-05-05) refers to 'our regeneration services product group'.
- Newer filing (2026-08-06) refers to 'our regenerated sulfuric acid product' in the Cost of Goods Sold section, while older filing (2026-05-05) refers to 'our regeneration services product group'.
- Newer filing (2026-08-06) states in Sales highlights that sales increase was 'partially offset by lower pricing due to customer mix and the pass-through of lower variable freight costs'; older filing (2026-05-05) does not include that offset language in highlights.
- Notes:
- The newer filing text is truncated at the beginning of the Interest Expense discussion for Q2 2026; the older filing text is also truncated during the Interest Expense, Net discussion for Q1 2026, so those portions could not be compared.
- Because the two filings cover different quarterly periods (Q2 2026 vs Q1 2026), reported figures and metrics differ by period and are not directly comparable as revisions of the same disclosure.
Risk Factors
- Added:
- Newer filing (2026-08-06) adds the sentence: 'We are a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide and related derivatives, which we believe are essential to our customers' operations and processes' to the Overview section.
- Newer filing (2026-08-06) adds the sentence beginning 'As a result of the recent June 30, 2026 acquisition of the Calabrian sulfur dioxide and sulfur derivatives business ("Calabrian"), we expanded our product offering into the sulfur dioxide, sodium bisulfite, sodium thiosulfate and sodium metabisulfite product groups...' to the Overview section.
- Newer filing (2026-08-06) adds the paragraph beginning 'On June 30, 2026 we completed our acquisition of the Calabrian business from INEOS Calabrian Holdings Limited...' including purchase price, cash paid, and financing details.
- Newer filing (2026-08-06) includes repurchase data for the six months ended June 30, 2025: 'For the six months ended June 30, 2025, the Company repurchased 2,926,152 shares of its common stock on the open market at an average price of $7.47 per share, for a total cost of $21.9 million excluding brokerage commissions and accrued excise tax.'
- Removed:
- Older filing (2026-05-05) contains the Overview sentence: 'We are a leading provider of virgin sulfuric acid and regenerated sulfuric acid products and services. We believe that our Ecoservices business contributes to improving the sustainability of the environment.' which is removed in the newer filing.
- Older filing (2026-05-05) contains the sentence: 'The Company did not repurchase any of its common stock pursuant to the stock repurchase program during the three months ended March 31, 2025.' which is not present in the newer filing.
- Reworded:
- Older filing (2026-05-05) Overview refers to 'We are a leading provider of sulfuric acid recycling to the North American refining industry...' while newer filing (2026-08-06) refers to 'We are a leading provider of regenerated sulfuric acid to the North American refining industry...'
- Older filing (2026-05-05) Stock Repurchase Program refers to 'For the three months ended March 31, 2026, the Company repurchased 3,226,461 shares...' while newer filing (2026-08-06) refers to 'For the six months ended June 30, 2026, the Company repurchased 3,226,461 shares...'
- Older filing (2026-05-05) Stock Repurchase Program states 'As of March 31, 2026, $146.5 million was available...' while newer filing (2026-08-06) states 'As of June 30, 2026, $146.5 million was available...'
- Older filing (2026-05-05) Key Performance Indicators uses 'net income (loss) from continuing operations' while newer filing (2026-08-06) uses 'net income from continuing operations' in the descriptions of EBITDA and Adjusted Net Income.
- Older filing (2026-05-05) Key Performance Indicators uses 'Reconciliations of Adjusted EBITDA, Adjusted Net Income to GAAP net income (loss) from continuing operations...' while newer filing (2026-08-06) uses 'Reconciliations of Adjusted EBITDA, Adjusted Net Income to GAAP net income from continuing operations...'
- Older filing (2026-05-05) describes the Advanced Materials & Catalysts sale as 'On December 31, 2025, the Company completed the sale...' while newer filing (2026-08-06) describes it as 'On December 31, 2025, we completed the sale...'
- Notes:
- Comparison is limited to the provided excerpt of the Risk Factors section from each filing, which may not include the complete section.
- The newer filing excerpt ends mid-sentence in the Key Performance Indicators section, so changes in subsequent text could not be assessed.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
1 open-market purchase and 0 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-16. The 6 days since 2026-10-16 have not been checked yet.
- Last 90 days · read to 2026-10-161 buy ($249994) · 0 sells — 1 buying insider
- Last 180 days · read to 2026-10-161 buy ($249994) · 1 sell ($112639) — 1 buying, 1 selling insiders
Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-09-10. Based on Form 4 filings read through 2026-10-16; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about ECVT's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding ECVT as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 19,767,125
- Reported value $246,100,707
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 4 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about ECVT's institutional holders → See what each manager we track holds →
Short interest (FINRA)
ECVT had 5,939,201 shares of reported short interest as of the 2026-09-30 FINRA settlement date (delayed, bi-monthly; not real-time).
ECVT had 5.43% of its shares outstanding sold short as of the 2026-09-30 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.43 days to cover at the same settlement.
- Reported short interest (shares) 5,939,201
- Short interest (% of shares outstanding) 5.43%
- Prior settlement (shares) 5,256,185
- Reported change 12.99%
- Days to cover (reported) 4.43
Reported to FINRA as of the 2026-09-30 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- W. R. Grace & Co.
- Evonik Industries (EVK.DE)
- Solvay (SOLB.BR)
- PQ Corporation
- BASF SE (BAS.DE)
- Arkema (AKE.PA)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Frequently asked questions
What does ECOVYST INC (ECVT) do?
Ecovyst Inc. is a specialty chemicals company that provides advanced material solutions and catalyst technologies. The company operates primarily through segments focused on high-performance silica catalysts and engineered silica materials, as well as high-purity sulfuric acid and related chemical services. Their products are essential in applications ranging from plastic production and refining to environmental emission control and renewable energy processes.
What sector is ECOVYST INC (ECVT) in?
ECOVYST INC (ECVT) is classified in the Materials sector. Its industry is Specialty Chemicals. It trades on NYSE.
Who are ECOVYST INC's (ECVT) competitors?
Notable peers of ECOVYST INC (ECVT) include W. R. Grace & Co., Evonik Industries, Solvay, PQ Corporation and BASF SE. This peer set is informational only — not financial advice.
Is ECOVYST INC (ECVT) overbought or oversold right now?
ECOVYST INC (ECVT) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 44, in the neutral middle (as of 2026-10-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ECVT come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.